News Releases

Beckman Coulter announced that it has filed a submission for 510(k) clearance with the U.S. Food and Drug Administration (FDA) for its Early Sepsis Indicator. The first-of-its-kind...

Agreement to focus on accelerating campus innovation from lab to real world via UCI Applied Innovation IRVINE, Calif. — (June 21, 2018) — Beckman Coulter Diagnostics, a global leader in the...

The new Access Sensitive Estradiol assay completes the comprehensive reproductive menu for Access immunoassay systems and provides better operational efficiency while delivering quality results....

Beckman Coulter announced today the positive results of a clinical trial suggesting that blood tests may offer key benefits in the initial screening for obstructive sleep apnea. The study, which...

Software version 2 enhancements improve flagging and streamline the quality control processes BREA, Calif. — (May 10, 2018) — Beckman Coulter Diagnostics announced today the global launch of...

First-of-its-kind hematology-based test intended to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis as part of a routine CBC with differential test...

Beckman Coulter announced today the release of the DxH 900 hematology analyzer, giving mid- to high-volume clinical laboratories the ability to perform complete blood count and white blood cell...

BREA, Calif. — (April 18, 2018) — Beckman Coulter Diagnostics announced achievement of CE Mark of its DxH 520 hematology analyzer, designed to help physician office laboratories deliver...

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced its exclusive sponsorship of the ESCAVO Sepsis Clinical Guide (Sepsis app), a point-of-care medical reference...

Beckman Coulter Diagnostics today announced commercialization of its Access Sensitive Estradiol in the U.S., with simultaneous commercial availability of its assay in the majority of global...